Qing Ye

5.4k total citations · 1 hit paper
54 papers, 2.4k citations indexed

About

Qing Ye is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Qing Ye has authored 54 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Public Health, Environmental and Occupational Health, 35 papers in Infectious Diseases and 13 papers in Epidemiology. Recurrent topics in Qing Ye's work include Mosquito-borne diseases and control (36 papers), Viral Infections and Vectors (30 papers) and Virology and Viral Diseases (8 papers). Qing Ye is often cited by papers focused on Mosquito-borne diseases and control (36 papers), Viral Infections and Vectors (30 papers) and Virology and Viral Diseases (8 papers). Qing Ye collaborates with scholars based in China, United States and Belarus. Qing Ye's co-authors include Cheng‐Feng Qin, Yong‐Qiang Deng, Zhiheng Xu, Lei Shi, Yisheng Jiang, Cui Li, Dan Xu, Nana Zhang, Xinyi Liu and Shuai Hong and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Virology.

In The Last Decade

Qing Ye

53 papers receiving 2.4k citations

Hit Papers

Zika Virus Disrupts Neural Progenitor Development and Lea... 2016 2026 2019 2022 2016 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing Ye China 27 1.6k 1.4k 583 475 256 54 2.4k
Renato Santana Aguiar Brazil 20 1.5k 0.9× 1.5k 1.1× 638 1.1× 423 0.9× 143 0.6× 76 2.6k
Natalie A. Prow Australia 30 1.8k 1.1× 1.7k 1.2× 318 0.5× 288 0.6× 483 1.9× 73 2.6k
Estefanı́a Fernández United States 17 2.6k 1.6× 2.2k 1.6× 1.3k 2.2× 493 1.0× 332 1.3× 22 3.5k
Chao Shan United States 32 2.2k 1.4× 2.5k 1.8× 783 1.3× 593 1.2× 512 2.0× 79 3.7k
Jennifer Govero United States 16 2.4k 1.5× 2.1k 1.5× 967 1.7× 325 0.7× 266 1.0× 25 3.1k
Marie Flamand France 22 2.0k 1.2× 1.7k 1.2× 223 0.4× 257 0.5× 150 0.6× 38 2.5k
Christina L. Gardner United States 23 1.1k 0.7× 1.1k 0.8× 249 0.4× 387 0.8× 88 0.3× 42 1.8k
Thérèse Couderc France 33 2.3k 1.4× 2.4k 1.7× 567 1.0× 591 1.2× 124 0.5× 56 3.7k
J. David Beckham United States 25 678 0.4× 842 0.6× 474 0.8× 326 0.7× 102 0.4× 64 1.8k
Shengbo Cao China 32 1.3k 0.8× 1.2k 0.9× 451 0.8× 794 1.7× 98 0.4× 125 3.0k

Countries citing papers authored by Qing Ye

Since Specialization
Citations

This map shows the geographic impact of Qing Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Ye more than expected).

Fields of papers citing papers by Qing Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Ye. The network helps show where Qing Ye may publish in the future.

Co-authorship network of co-authors of Qing Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Ye. A scholar is included among the top collaborators of Qing Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Ye. Qing Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Rongrong, Yilong Zhu, Wei Tang, et al.. (2023). Rational development of multicomponent mRNA vaccine candidates against mpox. Emerging Microbes & Infections. 12(1). 2192815–2192815. 60 indexed citations
2.
Yan, Hongyan, et al.. (2023). Regret Theory and Fuzzy-DEMATEL-Based Model for Construction Program Manager Selection in China. Buildings. 13(4). 838–838. 13 indexed citations
3.
Ye, Qing, Mei Wu, Chao Zhou, et al.. (2022). Rational development of a combined mRNA vaccine against COVID-19 and influenza. npj Vaccines. 7(1). 84–84. 33 indexed citations
4.
Cheng, Meng‐Li, Zhongyu Liu, Dan Wen, et al.. (2022). Pathogenicity and Structural Basis of Zika Variants with Glycan Loop Deletions in the Envelope Protein. Journal of Virology. 96(23). e0087922–e0087922. 3 indexed citations
5.
Zu, Shulong, Chunfeng Li, Lili Li, et al.. (2022). TRIM22 suppresses Zika virus replication by targeting NS1 and NS3 for proteasomal degradation. Cell & Bioscience. 12(1). 139–139. 20 indexed citations
6.
Shang, Jingzhe, Chunfeng Li, Shulong Zu, et al.. (2022). Immune profiles in mouse brain and testes infected by Zika virus with variable pathogenicity. Frontiers in Cellular and Infection Microbiology. 12. 948980–948980. 3 indexed citations
7.
Ni, Ling, Meng‐Li Cheng, Feng Yu, et al.. (2021). Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients. Frontiers in Immunology. 12. 603563–603563. 34 indexed citations
8.
Glaser, Talita, Roberta Andrejew, Ágatha Oliveira‐Giacomelli, et al.. (2020). Purinergic Receptors in Basal Ganglia Diseases: Shared Molecular Mechanisms between Huntington’s and Parkinson’s Disease. Neuroscience Bulletin. 36(11). 1299–1314. 22 indexed citations
9.
Chen, Qi, Jin Wu, Qing Ye, et al.. (2018). Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate. mBio. 9(5). 79 indexed citations
10.
Li, Cui, Qin Wang, Yisheng Jiang, et al.. (2018). Disruption of glial cell development by Zika virus contributes to severe microcephalic newborn mice. Cell Discovery. 4(1). 43–43. 42 indexed citations
11.
Ji, Xue, Qing Ye, Chunfeng Li, et al.. (2018). Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone. Nature Communications. 9(1). 673–673. 75 indexed citations
12.
Deng, Yong‐Qiang, Chunlin Li, Jianfeng Han, et al.. (2017). Phylogenetic and genetic characterization of a 2017 clinical isolate of H7N9 virus in Guangzhou, China during the fifth epidemic wave. Science China Life Sciences. 60(12). 1331–1339. 13 indexed citations
13.
Li, Xiaofeng, Xiaodan Li, Cheng‐Lin Deng, et al.. (2017). Visualization of a neurotropic flavivirus infection in mouse reveals unique viscerotropism controlled by host type I interferon signaling. Theranostics. 7(4). 912–925. 30 indexed citations
14.
Li, Cui, Dan Xu, Qing Ye, et al.. (2016). Zika Virus Disrupts Neural Progenitor Development and Leads to Microcephaly in Mice. Cell stem cell. 19(1). 120–126. 558 indexed citations breakdown →
15.
Ye, Qing, Zhongyu Liu, Jianfeng Han, et al.. (2016). Genomic characterization and phylogenetic analysis of Zika virus circulating in the Americas. Infection Genetics and Evolution. 43. 43–49. 86 indexed citations
16.
Wang, Guangchuan, Yaling He, Jianfeng Han, et al.. (2014). Crystal Structures of Enterovirus 71 (EV71) Recombinant Virus Particles Provide Insights into Vaccine Design. Journal of Biological Chemistry. 290(6). 3198–3208. 22 indexed citations
17.
Li, Xiaofeng, Qing Ye, Shihua Li, et al.. (2014). Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice. Vaccine. 32(8). 949–956. 28 indexed citations
18.
Li, Xiaofeng, Qing Ye, Yong‐Qiang Deng, et al.. (2014). Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2. Vaccine. 32(23). 2675–2681. 32 indexed citations
19.
Li, Xiaofeng, Yong‐Qiang Deng, Hui Zhao, et al.. (2013). Noninvasive bioluminescence imaging of dengue virus infection in the brain of A129 mice. Applied Microbiology and Biotechnology. 97(10). 4589–4596. 8 indexed citations
20.
Li, Shihua, Xiaofeng Li, Hui Zhao, et al.. (2013). Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2. Virology Journal. 10(1). 64–64. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026